Human ACE2 / Angiotensin-Converting Enzyme 2 Protein (Fc Tag) | Sino Biological 10108-H02H product information

product summary

company name :

Sino Biological

product type :

protein

product name :

Human ACE2 / Angiotensin-Converting Enzyme 2 Protein (Fc Tag)

catalog :

10108-H02H

quantity :

1 mg

price :

2430 USD

more info or order :

Sino Biological product webpage

citations: 20

Published Application/Species/Sample/Dilution	Reference
ELISA; human	Beddingfield B, Iwanaga N, Zheng W, Roy C, Hu T, Kolls J, et al. The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection. bioRxiv. 2020;: pubmed publisher
	STASKO N, Arwood L, Jandick N, Spragion D, Roberts R, Seti xe9 n M, et al. The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells. mSphere. 2025;10:e0023025 pubmed publisher
	Wang K, Pan Y, Wang D, Yuan Y, Li M, Chen Y, et al. Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry. Virol Sin. 2023;: pubmed publisher
	Amruta N, Maness N, Gressett T, Tsuchiya Y, Kishi M, Bix G. Effect of acetic acid inactivation of SARS-CoV-2. PLoS ONE. 2023;18:e0276578 pubmed publisher
	Wang Z, An J, Liu K, Yu P, Fang X, Li J, et al. A potent, broadly protective vaccine against SARS-CoV-2 variants of concern. NPJ Vaccines. 2022;7:144 pubmed publisher
	Song J, Chow R, Pe xf1 a Hern xe1 ndez M, Zhang L, Loeb S, So E, et al. LRRC15 inhibits SARS-CoV-2 cellular entry in trans. PLoS Biol. 2022;20:e3001805 pubmed publisher
	Wang R, Huang X, Cao T, Sun C, Luo D, Qiu H, et al. Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants. Virology. 2022;576:61-68 pubmed publisher
	Liu H, Kaku C, Song G, Yuan M, Andrabi R, Burton D, et al. Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron. Commun Biol. 2022;5:766 pubmed publisher
	Fang Z, Peng L, Filler R, Suzuki K, McNamara A, Lin Q, et al. Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2. bioRxiv. 2022;: pubmed publisher
	Bao L, Zhang C, Lyu J, Yi P, Shen X, Tang B, et al. Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker. J Appl Microbiol. 2022;132:2421-2430 pubmed publisher
	Shalash A, Azuar A, Madge H, Modhiran N, Amarilla A, Liang B, et al. Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay. Vaccines (Basel). 2021;9: pubmed publisher
	Song J, Chow R, Pena Hernandez M, Zhang L, Loeb S, So E, et al. LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans. bioRxiv. 2021;: pubmed publisher
	Liu H, Zhou C, An J, Song Y, Yu P, Li J, et al. Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants. Vaccine. 2021;39:7001-7011 pubmed publisher
	Huang C, Tan Z, Zhao K, Zou W, Wang H, Gao H, et al. The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor. iScience. 2021;24:103272 pubmed publisher
	Han S, Zhao G, Wei Z, Chen Y, Zhao J, He Y, et al. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade. Peptides. 2021;145:170638 pubmed publisher
	Du P, Chou Y, Santos H, Keskin B, Hsieh M, Ho T, et al. Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis. Anal Chem. 2021;93:7690-7698 pubmed publisher
	Wang C, Wang S, Li D, Chen P, Han S, Zhao G, et al. Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone. ACS Infect Dis. 2021;7:1545-1554 pubmed publisher
	Kim K, Bhatnagar N, Jeeva S, Oh J, Park B, Shin C, et al. Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines (Basel). 2021;9: pubmed publisher
	Rappazzo C, Tse L, Kaku C, Wrapp D, Sakharkar M, Huang D, et al. An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19. bioRxiv. 2020;: pubmed publisher
	McCallum M, Walls A, Bowen J, Corti D, Veesler D. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat Struct Mol Biol. 2020;27:942-949 pubmed publisher

image

image 1 :

product information

Catalog Number :

10108-H02H

Product Name :

Human ACE2 / Angiotensin-Converting Enzyme 2 Protein (Fc Tag)

Product Type :

Protein

Host Species :

HEK293 Cells

Conjugation :

C-human IgG1-Fc

Size :

1 mg

List Price :

2430 USD

Gene ID :

NP_068576.1

Product Description :

A DNA sequence encoding the extracellular domain (Met 1-Ser 740) of human ACE2 precursor (NP_068576.1) was expressed with the fused Fc region of human IgG1 at the C-terminus.

SpeciesSummary :

Human

ALTnames :

ACEH,UNQ868/PRO1885,ACE2

Purity :

≥ 95 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-HPLC.

Buffer :

Lyophilized from sterile 100mM Glycine, 10mM NaCl, 50mM Tris, pH 7.5

Packaging :

In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.

Storage :

Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

more info or order :

Sino Biological product webpage